See risks and benefits. Learn about the indications for SUTENT® (sunitinib malate) on the official patient website.

Drug therapy that treats kidney cancer in a few different ways. SUTENT is one of those therapies; it blocks an enzyme and keeps tumors from making their own blood vessels, which are needed to deliver oxygen and other nutrients to help them survive and grow. In so doing, SUTENT can slow cancer growth and may prevent the spread of cancer cells.

If you are prescribed SUTENT to treat gastrointestinal stromal tumor (GIST *) you may take 50 mg of SUTENT on a dosing cycle as follows: SUTENT is taken once every day for 4 weeks (28 …

SUTENT may cause serious side effects, including: Heart problems. Heart problems may include heart failure, heart attack and heart muscle problems (cardiomyopathy) that can lead to death. …

See risks & benefits. SUTENT® (sunitinib malate) is for adult patients with a rare cancer called GIST, when imatinib mesylate didn't work or you can't take it.

See risks and benefits. Important actions to take and information to remember before beginning treatment with SUTENT® (sunitinib malate).

In the clinical trial, patients taking SUTENT as adjuvant therapy started within 3 to 12 weeks after surgery. Talk to your doctor before or soon after surgery to determine if SUTENT is an option for you.

See risks and benefits. Learn about the financial assistance available for eligible patients taking SUTENT® (sunitinib malate).

See risks and benefits. SUTENT® (sunitinib malate) is for patients with pancreatic neuroendocrine tumors that have progressed & can't be treated with surgery.

SUTENT is used when the medicine Gleevec ® (imatinib mesylate) did not stop the cancer from growing, or when you cannot take Gleevec. SUTENT is used to treat a type of pancreatic …